Announcing Earth Day Plus (Apr 22 to May 3) – VC-Founder Matchup + Live Sessions. Learn More


Producing the active compounds from cannabis using yeast


Zach Wiltshire

COO & Co-Founder

Kevin Chen

CEO & Co-Founder

Shoham Mookerjee

CTO & Co-Founder

Alex Campbell

CSO & Co-Founder

Company details

Despite its increasing popularity in medicine, cannabis is too costly to produce at a large scale with the quality and consistency needed for medical use. Instead of depending on the cannabis plant and breeding new strains, we use engineered yeast to produce the same products, including THC, CBD, and even many of the minor cannabinoids, which are only found in small quantities in the plant. Compared to plants, our process is exponentially cheaper and faster while also giving patients, doctors, and researchers the quality they can depend on.

Get In Touch with Hyasynth

Please tell us a little bit about yourself and why you'd like to get connected. Hyasynth + SOSV will follow up with you via email.


No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.